Lofti Benboubker

Statistics

Publications

Citations

2.6K

H-Index

Active since

2004

Affiliations

Centre Hospitalier Universitaire de Tours(Current)

Hôpital Claude Huriez

Hôpital Purpan

Mayo Clinic in Arizona

Inserm

Lofti Benboubker is an author at Centre Hospitalier Universitaire de Tours specializing in medicine, hematologic malignancy therapy, and multiple myeloma therapy.

Publications per year

2004–2022

Publications

Lenalidomide Maintenance after Stem-Cell Transplantation for Multiple Myeloma

Michel Attal, Valérie Lauwers‐Cancès, Gérald Marit et al. · New England Journal of Medicine · 2012 · 1.2K citations · Full text

Medicine, Oncology, Pharmacotherapy +13

Efficacy of venetoclax as targeted therapy for relapsed/refractory t(11;14) multiple myeloma

Shaji Kumar, Jonathan L. Kaufman, Cristina Gasparetto et al. · Blood · 2017 · 527 citations · Full text

Medicine, Hematology, Immunology +11

Bortezomib plus dexamethasone as induction treatment prior to autologous stem cell transplantation in patients with newly diagnosed multiple myeloma: results of an IFM phase II study.

Jean‐Luc Harousseau, Michel Attal, Xavier Leleu et al. · PubMed · 2006 · 335 citations

Medicine, Pharmacology, Pharmacotherapy +15

VELCADE/Dexamethasone (Vel/Dex) Versus VAD as Induction Treatment Prior to Autologous Stem Cell Transplantation (ASCT) in Newly Diagnosed Multiple Myeloma (MM): An Interim Analysis of the IFM 2005-01 Randomized Multicenter Phase III Trial.

Jean‐Luc Harousseau, Gérald Marit, Denis Caillot et al. · Blood · 2006 · 74 citations

Medicine, Hematology, Oncology +17

Pomalidomide, cyclophosphamide, and dexamethasone for relapsed multiple myeloma

Laurent Garderet, Frédérique Kuhnowski, Benoit Berge et al. · Blood · 2018 · 65 citations · Full text

Medicine, Hematology, Oncology +10

1–5 of 22